Background
==========

Complement anaphylatoxin 5a (C5a) is a powerful inflammatory mediator involved in the pathology of inflammatory diseases such as chronic idiopathic urticaria. C5a binds to two receptors, C5aR, a G protein-coupled receptor, and C5L2, a 7-transmembrane receptor deficient in G protein coupling. The role of C5L2 in human mast cells (huMC) is unknown. We hypothesized that huMC express C5aR and/or C5L2 and C5a activates huMC to produce pro-inflammatory mediators through one or both of these receptors.

Methods
=======

C5aR and C5L2 expression on the huMC line, LAD2, was analyzed by quantitative PCR and flow cytometry. Degranulation was measured by β-hexosaminidase assay. Eicosanoids and cytokines/chemokines production was measured by ELISA and cytometric bead array. C5L2 expression was knocked-out using C5L2 shRNA lentiviral particles (LvP) and a stably C5L2^-^ cell line was selected for further analysis of C5L2 function.

Results
=======

LAD2 expressed mRNA for C5aR and C5L2. However, flow cytometry analysis showed that LAD2 expressed surface C5L2 but not C5aR. C5a stimulated LAD2 to produce TNF (22±1.3pg/ml), GM-CSF (15±0.4pg/ml), MCP-1 (53±3.6pg/ml) and IP-10 (32±4.3pg/ml). C5a failed to degranulate LAD2 and generate eicosanoids. C5L2 shRNA LvP completely knocked-out C5L2 expression. C5L2-depleted LAD2 did not respond to C5a while control shRNA-treated LAD2 did.

Conclusions
===========

LAD2 express C5L2 but not C5aR, and C5a induces production of cytokines/chemokines suggesting that C5L2 is an excitatory receptor in huMC. Knock-down of C5L2 abrogates C5a function. This is the first study to demonstrate a functional role of C5L2 in huMC. The observation that C5L2, not C5aR, may be more important in complement-mediated activation of huMC may provide novel insights into treatment of complement-mediated inflammation.
